Display Settings:

Format

Send to:

Choose Destination
    Lancet. 1989 Nov 11;2(8672):1142-5.

    International trial of long-term dexfenfluramine in obesity.

    Source

    Department of Medicine and Nutrition, Hôtel-Dieu, Paris, France.

    Abstract

    In a randomised, placebo-controlled, double-blind study, 822 obese patients of both sexes were given either dexfenfluramine (dF), 15 mg twice daily (404), or placebo (418) in addition to a calorie-restricted diet for 1 year. Patients in both groups lost weight significantly in the first 6 months; after 6 months dF patients had a higher cumulative mean weight loss. Dropout rates were lower in dF patients than in placebo patients, mainly because of dissatisfaction with weight loss in the latter group. More than twice as many dF patients as placebo patients achieved a given weight loss; but more dF patients than placebo patients had transient side-effects (tiredness, diarrhoea, dry mouth, polyuria, and drowsiness).

    PMID:
    2572857
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Chemical compound information

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk